跳至主要内容
临床试验/NCT04129697
NCT04129697Unknown不适用

Intratympanic Dexamethasone or Methylprednisolone for Sudden Hearing Loss as a Salvage Treatment: a Randomized, Double-blind, Multi-center Study

Second Affiliated Hospital, School of Medicine, Zhejiang University0 个研究点目标入组 30 人开始时间: 2020年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
30
主要终点
hearing

研究概览

简要总结

For patients with sudden hearing loss, the initial treatment is not usually effective. We use Dexamethasone or Methylprednisolone to be an Intratympanic steroid administration as a salvage treatment. An randomized, double-blind, multi-center study is designed to find the difference between Dexamethasone or Methylprednisolone.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • sudden hearing loss and initial treatment is not effective

排除标准

  • the patients refused intratympanic steroids treatment.

研究组 & 干预措施

Dexamethasone

Active Comparator

干预措施: Dexamethasone or Methylprednisolone (Drug)

Methylprednisolone

Active Comparator

干预措施: Dexamethasone or Methylprednisolone (Drug)

结局指标

主要结局

hearing

时间窗: six month

the hearing level after treatment

次要结局

未报告次要终点

研究者

发起方
Second Affiliated Hospital, School of Medicine, Zhejiang University
申办方类型
Other
责任方
Sponsor

相似试验